Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR
sciencedirect.com/science/article/pii/S193652...Posted Dec 1, 2025, 4:00 AM UTC
20
sciencedirect.com
Loading comments…
Posted Dec 1, 2025, 4:00 AM UTC